Yoshino, T, Kim, T W, Yong, W P, Shiu, K-K, Jensen, B V, Jensen, L H, Smith, D, Garcia-Carbonero, R, Alcaide-Garcia, J, Gibbs, P, De la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, D T, Yang, P, Farooqui, M, Marinello, P, Diaz, L A & Andre, T 2021, ' Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177 ', Annals of Oncology, vol. 32, no. Suppl. 4, PS1-2, pp. S284 . https://doi.org/10.1016/j.annonc.2021.05.518